Literature DB >> 4306125

Reversible respiratory paralysis associated with polymyxin therapy.

L A Lindesmith, R D Baines, D B Bigelow, T L Petty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4306125     DOI： 10.7326/0003-4819-68-2-318

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  20 in total

1.  Polymyxin B infusion leading to cardiac arrest: a case report and literature review.

Authors:  M B Berie; M S King; I P Thomsen
Journal:  Infection       Date:  2014-11-15       Impact factor: 3.553

2.  Polymyxin use associated with respiratory arrest.

Authors:  Hannah Wunsch; Vivek K Moitra; Mona Patel; Amy L Dzierba
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.

Authors:  Matthew E Falagas; Sofia K Kasiakou; Sotirios Tsiodras; Argyris Michalopoulos
Journal:  Clin Med Res       Date:  2006-06

Review 4.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

5.  Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.

Authors:  Istemi Han Celik; Serife Suna Oguz; Gamze Demirel; Omer Erdeve; Ugur Dilmen
Journal:  Eur J Pediatr       Date:  2011-08-02       Impact factor: 3.183

Review 6.  Pancuronium bromide: a review of its pharmacological properties and clinical application.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 7.  Acute neuromuscular respiratory paralysis.

Authors:  R A Hughes; D Bihari
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

Review 8.  Infectious disease emergencies. Part III: Patients presenting with respiratory distress syndromes.

Authors:  P A Oill; S M Roser; J E Galpin; I Ziment; P A Selecky; J Schofferman
Journal:  West J Med       Date:  1976-12

9.  Rare cardiopulmonary complications of chronically decompensated myasthenia gravis.

Authors:  J C Chisholm; A Gilson
Journal:  J Natl Med Assoc       Date:  1980-10       Impact factor: 1.798

10.  Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B.

Authors:  Josiane F John; Diego R Falci; Maria Helena Rigatto; Renata D Oliveira; Thaysa G Kremer; Alexandre P Zavascki
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.